Amneal Pharmaceuticals, Inc. (AMRX) financial statements (2020 and earlier)

Company profile

Business Address
,
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments213213 
Cash and cash equivalents213213 
Restricted cash and investments45 
Receivables520529 
Inventory, net of allowances, customer advances and progress billings402457 
Inventory402457 
Prepaid expense 38 
Contract with customer, asset 2
Other undisclosed current assets6741 
Total current assets:1,2061,287 
Noncurrent Assets
Operating lease, right-of-use asset71
Property, plant and equipment491544 
Intangible assets, net (including goodwill)1,8552,081 
Goodwill420426 
Intangible assets, net (excluding goodwill)1,4361,655 
Other noncurrent assets1968 
Other undisclosed noncurrent assets62373 
Total noncurrent assets:2,4983,066 
TOTAL ASSETS:3,7044,353 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:496514 
Accounts payable 115 
Accrued liabilities 66 
Employee-related liabilities 77 
Other undisclosed accounts payable and accrued liabilities496257 
Debt2121 
Due to related parties118 
Other undisclosed current liabilities170 
Total current liabilities:535554 
Noncurrent Liabilities
Long-term debt and lease obligation2,6142,670 
Long-term debt, excluding current maturities2,6142,631 
Capital lease obligations39 
Liabilities, other than long-term debt3939 
Other liabilities3939 
Other undisclosed noncurrent liabilities120194 
Total noncurrent liabilities:2,7732,903 
Total liabilities:3,3083,456 
Stockholders' equity
Stockholders' equity attributable to parent, including:218505 
Common stock  0
Additional paid in capital566530 
Accumulated other comprehensive loss(5)(8) 
Accumulated deficit(346)(21) 
Receivable from shareholders or affiliates for issuance of capital stock  (0)
Other undisclosed stockholders' equity attributable to parent33 
Stockholders' equity attributable to noncontrolling interest178392 
Total stockholders' equity:396896 
TOTAL LIABILITIES AND EQUITY:3,7044,353 

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
Revenues1,7271,663 
Cost of revenue
(Cost of Goods and Services Sold)
(1,178)(947) 
Other undisclosed gross profit(112)  
Gross profit:436716 
Operating expenses(631)(533) 
Other undisclosed operating loss(7)(203) 
Operating loss:(202)(20) 
Nonoperating income (expense)24(183) 
Investment income, nonoperating7(3) 
Foreign currency transaction loss, before tax(10)(20) 
Interest and debt expense(5)(6) 
Loss from continuing operations before equity method investments, income taxes:(183)(209) 
Other undisclosed income from continuing operations before income taxes56 
Loss from continuing operations before income taxes:(178)(203) 
Income tax expense (benefit)(381)1 
Net loss:(559)(201) 
Net income attributable to noncontrolling interest22033 
Other undisclosed net income attributable to parent 149 
Net loss attributable to parent:(339)(20) 
Preferred stock dividends and other adjustments (1) 
Net loss available to common stockholders, diluted:(339)(21) 

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
Net loss:(559)(201) 
Comprehensive loss:(559)(201) 
Comprehensive income, net of tax, attributable to noncontrolling interest21336 
Other undisclosed comprehensive income, net of tax, attributable to parent12142 
Comprehensive loss, net of tax, attributable to parent:(333)(23) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: